Literature DB >> 27558268

Evidence-based (S3) guidelines for diagnostics and treatment of venous leg ulcers.

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27558268     DOI： 10.1111/jdv.13848

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  7 in total

Review 1.  ABPI reporting and compression recommendations in global clinical practice guidelines on venous leg ulcer management: A scoping review.

Authors:  Carolina D Weller; Victoria Team; John D Ivory; Kimberley Crawford; Georgina Gethin
Journal:  Int Wound J       Date:  2018-11-28       Impact factor: 3.315

2.  Trichloroacetic acid (80%) as a chemical debridement method for chronic venous leg ulcers-A pilot study.

Authors:  Rita R Pinheiro; Bruno Duarte; Joana Cabete
Journal:  Int Wound J       Date:  2018-01-15       Impact factor: 3.315

Review 3.  An estimate of the economic burden of venous leg ulcers associated with deep venous disease.

Authors:  Raghu Kolluri; Marzia Lugli; Laurencia Villalba; Ramon Varcoe; Oscar Maleti; Fernando Gallardo; Stephen Black; Fannie Forgues; Michael Lichtenberg; Jordan Hinahara; Saranya Ramakrishnan; Joshua A Beckman
Journal:  Vasc Med       Date:  2021-08-16       Impact factor: 3.239

Review 4.  Effects of physical activity as an adjunct treatment on healing outcomes and recurrence of venous leg ulcers: A scoping review.

Authors:  Yunjing Qiu; Christian R Osadnik; Victoria Team; Carolina D Weller
Journal:  Wound Repair Regen       Date:  2022-02-10       Impact factor: 3.401

5.  Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data.

Authors:  Andreas Kerstan; Elke Niebergall-Roth; Jasmina Esterlechner; Hannes M Schröder; Martin Gasser; Ana M Waaga-Gasser; Matthias Goebeler; Katrin Rak; Philipp Schrüfer; Sabrina Endres; Petra Hagenbusch; Korinna Kraft; Kathrin Dieter; Seda Ballikaya; Nicole Stemler; Samar Sadeghi; Nils Tappenbeck; George F Murphy; Dennis P Orgill; Natasha Y Frank; Christoph Ganss; Karin Scharffetter-Kochanek; Markus H Frank; Mark A Kluth
Journal:  Cytotherapy       Date:  2020-10-01       Impact factor: 5.414

6.  Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.

Authors:  Andreas Kerstan; Kathrin Dieter; Elke Niebergall-Roth; Ann-Kathrin Dachtler; Korinna Kraft; Markus Stücker; Georg Daeschlein; Michael Jünger; Tobias Görge; Ulrich Meyer-Pannwitt; Cornelia Erfurt-Berge; Charlotte von Engelhardt; Andreas Klare; Christiane Pfeiffer; Jasmina Esterlechner; Hannes M Schröder; Martin Gasser; Ana M Waaga-Gasser; Matthias Goebeler; Seda Ballikaya; Samar Sadeghi; George F Murphy; Dennis P Orgill; Natasha Y Frank; Christoph Ganss; Karin Scharffetter-Kochanek; Markus H Frank; Mark A Kluth
Journal:  JID Innov       Date:  2021-10-25

7.  The safety and efficacy of Sclerosing foam on treating venous leg ulcers: Protocol for systematic review and meta-analysis.

Authors:  Weijing Fan; Xiao Yang; Baozhong Yang; Changgeng Fu; Renyan Huang; Feng Xv; Guobin Liu
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.